» Articles » PMID: 22157719

Multiple Roles of the Epithelium-specific ETS Transcription Factor, ESE-1, in Development and Disease

Overview
Journal Lab Invest
Specialty Pathology
Date 2011 Dec 14
PMID 22157719
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The E26 transformation-specific (ETS) family of transcription factors comprises of 27 and 26 members in humans and mice, respectively, which are known to regulate many different biological processes, including cell proliferation, cell differentiation, embryonic development, neoplasia, hematopoiesis, angiogenesis, and inflammation. The epithelium-specific ETS transcription factor-1 (ESE-1) is a physiologically important ETS transcription factor, which has been shown to play a role in the pathogenesis of various diseases, and was originally characterized as having an epithelial-restricted expression pattern, thus placing it within the epithelium-specific ETS subfamily. Despite a large body of published work on ETS biology, much remains to be learned about the precise functions of ESE-1 and other epithelium-specific ETS factors in regulating diverse disease processes. Clues as to the specific function of ESE-1 in the setting of various diseases can be obtained from studies aimed at examining the expression of putative target genes regulated by ESE-1. Thus, this review will focus primarily on the various roles of ESE-1 in different pathophysiological processes, including regulation of epithelial cell differentiation during both intestinal development and lung regeneration; regulation of dendritic cell-driven T-cell differentiation during allergic airway inflammation; regulation of mammary gland development and breast cancer; and regulation of the effects of inflammatory stimuli within the setting of synovial joint and vascular inflammation. Understanding the exact mechanisms by which ESE-1 regulates these processes can have important implications for the treatment of a wide range of diseases.

Citing Articles

Structural Variation Analysis in the samd3/elf3 Intergenic Region of the Barred knifejaw (Oplegnathus fasciatus) and the Development of Molecular Marker for Efficient Sex Identification.

Xu P, Xiao Y, Xiao Z, Li J Mar Biotechnol (NY). 2025; 27(1):40.

PMID: 39891748 DOI: 10.1007/s10126-025-10417-0.


PI3K/AKT pathway as a pivotal regulator of epithelial-mesenchymal transition in lung tumor cells.

Moghbeli M Cancer Cell Int. 2024; 24(1):165.

PMID: 38730433 PMC: 11084110. DOI: 10.1186/s12935-024-03357-7.


ELF5 drives angiogenesis suppression though stabilizing WDTC1 in renal cell carcinoma.

Li T, Xu L, Wei Z, Zhang S, Liu X, Yang Y Mol Cancer. 2023; 22(1):184.

PMID: 37980532 PMC: 10656961. DOI: 10.1186/s12943-023-01871-2.


Single cell transcriptomic analysis of HPV16-infected epithelium identifies a keratinocyte subpopulation implicated in cancer.

Bedard M, Chihanga T, Carlile A, Jackson R, Brusadelli M, Lee D Nat Commun. 2023; 14(1):1975.

PMID: 37031202 PMC: 10082832. DOI: 10.1038/s41467-023-37377-0.


An integrative epigenomic approach identifies ELF3 as an oncogenic regulator in ASCL1-positive neuroendocrine carcinoma.

Horie M, Tanaka H, Suzuki M, Sato Y, Takata S, Takai E Cancer Sci. 2023; 114(6):2596-2608.

PMID: 36840413 PMC: 10236617. DOI: 10.1111/cas.15764.